EP3154559
USE OF SERELAXIN TO REDUCE GDF-15
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.6.2015EP published:
1.9.2021EP application number:
15730858.6
EPO information:
European Patent Register
Max expiry date:
9.6.2035
Title:
USE OF SERELAXIN TO REDUCE GDF-15
Timeline
Today
10.6.2015EP application
1.9.2021EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
PRESCOTT, Margaret ForneyAddress:
East Hanover, New Jersey 07936-1080, US
Name:
ZHANG, YimingAddress:
East Hanover, New Jersey 07936-1080, US
Name:
DAHLKE, MarionAddress:
CH-4056 Basel, CH
Name:
SEVERIN, ThomasAddress:
4056 Basel, CH
Priority
Number:
201462011744 PDate:
13.6.2014Country:
US
Classification
Categories:
A61K 38/00, A61K 38/22, A61B 5/00, A61P 9/00, A61P 11/00, A61P 9/04